MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
70 hedge funds and large institutions have $137M invested in Merrimack Pharmaceuticals, Inc. in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 21
Holders
70
Holding in Top 10
3
Calls
$1.86M
Puts
$47K
Top Buyers
| 1 | +$5.21M | |
| 2 | +$3.91M | |
| 3 | +$1.67M | |
| 4 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$984K |
| 5 |
State Street
Boston,
Massachusetts
|
+$741K |
Top Sellers
| 1 | -$3.87M | |
| 2 | -$3M | |
| 3 | -$2.65M | |
| 4 |
MAP
Madison Avenue Partners
New York
|
-$2.45M |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$805K |